CONTENTS:
- Addressing sex and gender inequities in scientific research and publishing [Editorial]. Del Boca F.K., p. 1323-1325.
- Building social and population science in alcohol and other drug studies [Editorial]. Room R., p. 1326-1327.
- Should academic journals publish e-cigarette research linked to tobacco companies? [For debate]. Shaw D.M., Etter J.-F., Elger B.S., p. 1328-1332.
- Navigating conflicts of interest in a rapidly changing research landscape. Munafo M.R., p. 1333-1334.
- Ethical issues raised by tobacco industry-linked research in the era of e-cigarettes. McCambridge J., p. 1334-1335.
- Treating tobacco companies fairly but with no leap of faith. Shaw D.M., Etter J.-F., Elger B.S., p. 1335-1336.
- Topiramate for cocaine dependence: a systematic review and meta-analysis of randomized controlled trials. Singh M., Keer D., Klimas J., Wood E., Werb D., p. 1337-1346.
- Commentary on Singh et al. (2016): Still searching for the answer. Darke S., Farrell M., p. 1347.
- The effects of cannabis intoxication on motor vehicle collision revisited and revised. Rogeberg O., Elvik R., p. 1348-1359.
- Daily alcohol use as an independent risk factor for HIV seroconversion among people who inject drugs. Young S.V., Wood E., Dong H., Kerr T., Hayashi K., p. 1360-1365.
- Gender-specific effects of comorbid depression and anxiety on the propensity to drink in negative emotional states. Karpyak V.M., Biernacka J.M., Geske J.R., Abulseoud O.A., Brunner M.D., Chauhan M., et al., p. 1366-1375.
- Estimating demand for primary care-based treatment for substance and alcohol use disorders. Barry C.L., Epstein A.J., Fiellin D.A., Fraenkel L., Busch S.H., p. 1376-1384.
- A randomized trial of a pain management intervention for adults receiving substance use disorder treatment. Ilgen M.A., Bohnert A.S.B., Chermack S., Conran C., Jannausch M., Trafton J., et al., p. 1385-1393.
- Commentary on Ilgen et al. (2016): Integrating chronic pain programs into addiction treatment - full steam ahead. Becker W.C., p. 1394-1395.
- Effectiveness of a universal internet-based prevention program for ecstasy and new psychoactive substances: a cluster randomized controlled trial. Champion K.E., Newton N.C., Stapinski L.A., Teesson M., p. 1396-1405.
- A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults. Marsch L.A., Moore S.K., Borodovsky J.T., Solhkhah R., Badger G.J., Semino S., et al., p. 1406-1415.
- Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study. Ling W., Hillhouse M.P., Saxon A.J., Mooney L.J., Thomas C.M., Ang A., et al., p. 1416-1427.
- Problem gambling and the five-factor model of personality: a large population-based study. Brunborg G.S., Hanss D., Mentzoni R.A., Molde H., Pallesen S., p. 1428-1435.
- Commentary on Brunborg et al. (2016): Personality research allows for a better understanding of the etiology and treatment of addictive behaviors. King S.M., p. 1436-1437.
- Depression motivates quit attempts but predicts relapse: differential findings for gender from the International Tobacco Control Study. Cooper J., Borland R., McKee S.A., Yong H.-H., Dugué P.-A., p. 1438-1447.
- The impact of quitting smoking on depressive symptoms: findings from the International Tobacco Control Four-Country Survey. Cooper J., Borland R., Yong H.-H., Fotuhi O., p. 1448-1456.
- Adolescent smoking and tertiary education: opposing pathways linking socio-economic background to alcohol consumption. Green M.J., Leyland A.H., Sweeting H., Benzeval M., p. 1457-1465.
- Ecological momentary assessment of working memory under conditions of simultaneous marijuana and tobacco use. Schuster R.M., Mermelstein R.J., Hedeker D., p. 1466-1476.
- Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers. Fitzgerald N., Angus K., Elders A., de Andrade M., Raistrick D., Heather N., et al., p. 1477-1487.
- Correcting the record on NCRG-funded research. Cottler L.B., Chung T., Hodgins D.C., Jorgensen M., Miele G., p. 1488-1489.
- Reply to Cottler et al.'s Letter to the Editor. Babor T.F., Miller P.R., Robaina K., p. 1489-1489.
- The NCRG Firewall Works. Cottler L.B., Chung T., Hodgins D.C., Jorgensen M., Miele G., p. 1489-1490.
- Reply to Cottler et al. (2016): The NCRG firewall works more for the gambling industry than for the scientific community. Babor T.F., p. 1491-1492.
- Risk for involvement in road traffic crash during acute cannabis intoxication. Gjerde H., Mørland J., p. 1492-1495.
- Response: Cannabis intoxication, recent use and road traffic crash risks. Rogeberg O., Elvik R., p. 1495-1498.
- Addiction training for health professionals as an antidote to the addiction health burden in Indonesia. Ayu A.P., Iskandar S., Siste K., De Jong C., Schellekens A., p. 1498-1499.